These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 16780912

  • 21. Expression of IL-2 and IL-4 in T lymphocytes transformed by herpesvirus saimiri.
    Chou CS, Medveczky MM, Geck P, Vercelli D, Medveczky PG.
    Virology; 1995 Apr 20; 208(2):418-26. PubMed ID: 7747414
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type I replication in an astrocytic glial cell.
    Niikura M, Dornadula G, Zhang H, Mukhtar M, Lingxun D, Khalili K, Bagasra O, Pomerantz RJ.
    Oncogene; 1996 Jul 18; 13(2):313-22. PubMed ID: 8710370
    [Abstract] [Full Text] [Related]

  • 24. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication.
    Accolla RS, Mazza S, De Lerma Barbaro A, De Maria A, Tosi G.
    Eur J Immunol; 2002 Oct 18; 32(10):2783-91. PubMed ID: 12355430
    [Abstract] [Full Text] [Related]

  • 25. Lck protein tyrosine kinase is a key regulator of T-cell activation and a target for signal intervention by Herpesvirus saimiri and other viral gene products.
    Isakov N, Biesinger B.
    Eur J Biochem; 2000 Jun 18; 267(12):3413-21. PubMed ID: 10848956
    [Abstract] [Full Text] [Related]

  • 26. The herpesvirus saimiri tip484 and tip488 proteins both stimulate lck tyrosine protein kinase activity in vivo and in vitro.
    Kjellen P, Amdjadi K, Lund TC, Medveczky PG, Sefton BM.
    Virology; 2002 Jun 05; 297(2):281-8. PubMed ID: 12083826
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
    Okamoto H, Cujec TP, Okamoto M, Peterlin BM, Baba M, Okamoto T.
    Virology; 2000 Jul 05; 272(2):402-8. PubMed ID: 10873784
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of tat-mediated HIV-1-LTR transactivation and virus replication by sulfhydryl compounds with chelating properties.
    Demirhan I, Chandra A, Sarin PS, Hasselmayer O, Hofmann D, Chandra P.
    Anticancer Res; 2000 Jul 05; 20(4):2513-7. PubMed ID: 10953320
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine.
    Jiang MC, Lin JK, Chen SS.
    Biochem Biophys Res Commun; 1996 Sep 04; 226(1):1-7. PubMed ID: 8806583
    [Abstract] [Full Text] [Related]

  • 30. The product of the Herpesvirus saimiri open reading frame 1 (tip) interacts with T cell-specific kinase p56lck in transformed cells.
    Biesinger B, Tsygankov AY, Fickenscher H, Emmrich F, Fleckenstein B, Bolen JB, Bröker BM.
    J Biol Chem; 1995 Mar 03; 270(9):4729-34. PubMed ID: 7876245
    [Abstract] [Full Text] [Related]

  • 31. The Lck binding domain of herpesvirus saimiri tip-484 constitutively activates Lck and STAT3 in T cells.
    Lund TC, Prator PC, Medveczky MM, Medveczky PG.
    J Virol; 1999 Feb 03; 73(2):1689-94. PubMed ID: 9882381
    [Abstract] [Full Text] [Related]

  • 32. Herpesvirus saimiri Tip-484 membrane protein markedly increases p56lck activity in T cells.
    Lund T, Medveczky MM, Medveczky PG.
    J Virol; 1997 Jan 03; 71(1):378-82. PubMed ID: 8985360
    [Abstract] [Full Text] [Related]

  • 33. Cutting edge: a short polypeptide domain of HIV-1-Tat protein mediates pathogenesis.
    Boykins RA, Mahieux R, Shankavaram UT, Gho YS, Lee SF, Hewlett IK, Wahl LM, Kleinman HK, Brady JN, Yamada KM, Dhawan S.
    J Immunol; 1999 Jul 01; 163(1):15-20. PubMed ID: 10384093
    [Abstract] [Full Text] [Related]

  • 34. Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production.
    Christensen HS, Daher A, Soye KJ, Frankel LB, Alexander MR, Lainé S, Bannwarth S, Ong CL, Chung SW, Campbell SM, Purcell DF, Gatignol A.
    J Virol; 2007 May 01; 81(10):5121-31. PubMed ID: 17360756
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
    Plavec I, Agarwal M, Ho KE, Pineda M, Auten J, Baker J, Matsuzaki H, Escaich S, Bonyhadi M, Böhnlein E.
    Gene Ther; 1997 Feb 01; 4(2):128-39. PubMed ID: 9081703
    [Abstract] [Full Text] [Related]

  • 37. Rhadinovirus vector-derived human telomerase reverse transcriptase expression in primary T cells.
    Toptan T, Ensser A, Fickenscher H.
    Gene Ther; 2010 May 01; 17(5):653-61. PubMed ID: 20164858
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A protein phosphatase from human T cells augments tat transactivation of the human immunodeficiency virus type 1 long-terminal repeat.
    Bharucha DC, Zhou M, Nekhai S, Brady JN, Shukla RR, Kumar A.
    Virology; 2002 Apr 25; 296(1):6-16. PubMed ID: 12036313
    [Abstract] [Full Text] [Related]

  • 40. Activation of STAT transcription factors by herpesvirus Saimiri Tip-484 requires p56lck.
    Lund TC, Garcia R, Medveczky MM, Jove R, Medveczky PG.
    J Virol; 1997 Sep 25; 71(9):6677-82. PubMed ID: 9261390
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.